![](/img/cover-not-exists.png)
Randomized, placebo-controlled study of Lamifiban with thrombolytic therapy for the treatment of acute myocardial infarction: Rationale and design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) study
David J. Moliterno, Robert A. Harrington, Robert M. Califf, Hans J. Rapold, Eric J. TopolVolume:
2
Year:
1995
Language:
english
Pages:
5
DOI:
10.1007/bf01062706
File:
PDF, 583 KB
english, 1995